Safety and Efficacy of the CarboFix Pedicle Screw System
- Conditions
- Degenerative Disc DiseaseSpinal CurvaturesSpondylolisthesisSpinal StenosisTumor
- Interventions
- Device: Pedicle screw system
- Registration Number
- NCT02039232
- Lead Sponsor
- CarboFix Orthopedics Ltd.
- Brief Summary
The purpose of this study is to evaluate the safety and efficacy of CarboFix' Pedicle Screw System in the lumbar spine.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 46
- Subject is 18 years old or older.
- Confirmation that the physical examination of radiopathy, myelopathy or combination is in correlation with the affected level.
- Lumbar CT, MRI, or myelography confirms the level of involvement is consistent with the subject's examination.
- Informed consent given by the subject.
-
Subject is not eligible for fixation with market-available fixation means.
-
Familial history NF2.
-
Acute traumatic spinal injury with or without neurological signs.
-
Metabolic bone disease.
-
History of Paget's disease or other osteodystrophies whether acquired or congenital, including renal osteodystrophy, hyperthyroidism, hypothyroidism hyperparathyroidism, Ehrlers-Danlos-syndrome, osteogenesis imperfecta, achondroplasia, tuberculosis.
-
History of mental disorder or current psychiatric treatment.
-
Pregnancy and/or female subjects intending to become pregnant within the expected time frame of the study and/or female subjects of child bearing age who do not use conventional contraceptive methods.
-
Immune deficiency disease.
-
Infection in the location of the operative site, discitis, osteomyelitis, fever and/or leukocytosis (as diagnosed based on the results of CBC and ESR tests).
-
Scoliosis.
-
Treatment with drugs that may interfere with bone metabolism such as:
- Cumulative dose of 150 mg. of Prednisone or equivalent within the last 6 months.
- Calcitonin within the past 6 months.
- Bisphosphonates for 30 days or more within the last 12 months.
- Bone therapeutic doses of fluoride for 30 days or more within the last 12 months.
- Bone therapeutic doses of vitamin D or Vitamin D metabolites for 30 days or more within the last 6 months.
- Treatment by chemotherapy within the last 12 months.
-
Lack of willingness to make a commitment to return for required follow up visits.
-
Drug and/or alcohol abuse.
-
Morbid obesity.
-
Metal allergies.
-
Recent use of other investigational drugs or devices (within the past 30 days).
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description CarboFix Pedicle Screw System Pedicle screw system -
- Primary Outcome Measures
Name Time Method Fusion success 6 months post-operation
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Hillel Yafe MC;
š®š±Hadera;, Israel
Herzliya Medical Center
š®š±Herzliya, Israel